Authors:
Barkardottir, RB
Sarantaus, L
Arason, A
Vehmanen, P
Bendahl, PO
Kainu, T
Syrjakoski, K
Krahe, R
Huusko, P
Pyrhonen, S
Holli, K
Kallioniemi, OP
Egilsson, V
Kere, J
Nevanlinna, H
Citation: Rb. Barkardottir et al., Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families, EUR J HUM G, 9(10), 2001, pp. 773-779
Authors:
Bergthorsson, JT
Ejlertsen, B
Olsen, JH
Borg, A
Nielsen, KV
Barkardottir, RB
Klausen, S
Mouridsen, HT
Winther, K
Fenger, K
Niebuhr, A
Harboe, TL
Niebuhr, E
Citation: Jt. Bergthorsson et al., BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age, J MED GENET, 38(6), 2001, pp. 361-368
Authors:
Lakhani, SR
Gusterson, BA
Jacquemier, J
Sloane, JP
Anderson, TJ
van de Vijver, MJ
Venter, D
Freeman, A
Antoniou, A
McGuffog, L
Smyth, E
Steel, CM
Haites, N
Scott, RJ
Goldgar, D
Neuhausen, S
Daly, PA
Ormiston, W
McManus, R
Scherneck, S
Ponder, BAJ
Futreal, PA
Peto, J
Stoppa-Lyonnet, D
Bignon, YJ
Struewing, JP
Bishop, DT
Klijn, JGM
Devilee, P
Cornelisse, CJ
Lasset, C
Lenoir, G
Barkardottir, RB
Egilsson, V
Hamann, U
Chang-Claude, J
Sobol, H
Weber, B
Easton, DF
Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Authors:
Kainu, T
Juo, SHH
Desper, R
Schaffer, AA
Gillanders, E
Rozenblum, E
Freas-Lutz, D
Weaver, D
Stephan, D
Bailey-Wilson, J
Kallioniemi, OP
Tirkkonen, M
Syrjakoski, K
Kuukasjarvi, T
Koivisto, P
Karhu, R
Holli, K
Arason, A
Johannesdottir, G
Bergthorsson, JT
Johannsdottir, H
Egilsson, V
Barkardottir, RB
Johannsson, O
Haraldsson, K
Sandberg, T
Holmberg, E
Gronberg, H
Olsson, H
Borg, A
Vehmanen, P
Eerola, H
Heikkila, P
Pyrhonen, S
Nevanlinna, H
Citation: T. Kainu et al., Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus, P NAS US, 97(17), 2000, pp. 9603-9608
Authors:
Sigbjornsdottir, BI
Ragnarsson, G
Agnarsson, BA
Chen, HP
Barkardottir, RB
Egilsson, V
Ingvarsson, S
Citation: Bi. Sigbjornsdottir et al., Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer, J MED GENET, 37(5), 2000, pp. 342-347
Authors:
Ingvarsson, S
Agnarsson, BA
Sigbjornsdottir, BI
Kononen, J
Kallioniemi, OP
Barkardottir, RB
Kovatich, AJ
Schwarting, R
Hauck, WW
Huebner, K
McCue, PA
Citation: S. Ingvarsson et al., Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas, CANCER RES, 59(11), 1999, pp. 2682-2689
Authors:
Launonen, V
Laake, K
Huusko, P
Niederacher, D
Beckmann, MW
Barkardottir, RB
Geirsdottir, EK
Gudmundsson, J
Rio, P
Bignon, YJ
Seitz, S
Scherneck, S
Bieche, I
Champeme, MH
Birnbaum, D
White, G
Varley, J
Sztan, M
Olah, E
Osorio, A
Benitez, J
Spurr, N
Velikonja, N
Peterlin, B
Borg, A
Cleton-Jansen, AM
Devilee, P
Bloigu, R
Lidereau, R
Borresen-Dale, AL
Winqvist, R
Citation: V. Launonen et al., European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables, BR J CANC, 80(5-6), 1999, pp. 879-882
Authors:
Eiriksdottir, G
Johannesdottir, G
Ingvarsson, S
Bjornsdottir, IB
Jonasson, JG
Agnarsson, BA
Hallgrimsson, J
Gudmundsson, J
Egilsson, V
Sigurdsson, H
Barkardottir, RB
Citation: G. Eiriksdottir et al., Mapping lass of heterozygosity at chromosome 13q: Loss at 13q12-q13 is associated with breast tumour progression and poor prognosis, EUR J CANC, 34(13), 1998, pp. 2076-2081
Authors:
Devilee, P
Barkardottir, RB
Bevilacqua, G
Bignon, YJ
Bishop, T
Borg, A
Borresen-Dale, AL
Chang-Claude, J
Easton, D
Eyfjord, J
Feunteun, J
Goldgar, D
Haites, N
Holm, N
Kruse, T
Larsson, C
Lenoir, G
Lidereau, R
Nevanlinna, H
Ponder, B
Scherneck, S
Schmitt, F
Sobol, H
Solomon, E
Spurr, N
Steel, M
Stratton, M
Varley, J
Vasen, H
Vassilaros, S
Wagner, T
Willems, P
Winqvist, R
Citation: P. Devilee et al., Genetics and epidemiology of hereditary breast cancer, BIOM HLTH R, 24, 1998, pp. 339-346